Sezary syndrome: Cutaneous immunoperoxidase double-labeling technique demonstrates CD4/CD8 ratio non-specificity

Journal of Cutaneous Pathology

Volumn 30, Issue 7, 2003, Pages 437-442

  Balfour, Erika M ^a   Glusac, Earl J ^b   Heald, Peter ^b   Talley, Lori L ^a   Smoller, Bruce R ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CD4 ANTIGEN; CD8 ANTIGEN; HORSERADISH PEROXIDASE; PEROXIDASE; TUMOR MARKER;

ARTICLE; BIOPSY; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; ERYTHRODERMIC MYCOSIS FUNGOIDES; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOPEROXIDASE STAINING; INFLAMMATORY DISEASE; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; METABOLISM; METHODOLOGY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SEZARY SYNDROME; SKIN BIOPSY; SKIN TUMOR; STAINING; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION;

ALKALINE PHOSPHATASE; BIOPSY; CD4-CD8 RATIO; HORSERADISH PEROXIDASE; HUMANS; IMMUNOENZYME TECHNIQUES; SENSITIVITY AND SPECIFICITY; SEZARY SYNDROME; SKIN NEOPLASMS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 0041665109     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2003.00059.x     Document Type: Article

References (13)

1. Willemze R, Kerl H, Sterry W, et al. EORTC Classification for Primary Cutaneous Lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354.
2. Kohler S, Kim YH, Smoller BR. Histologic criteria for the diagnosis of erythrodermic mycosis fungoides and Sezary syndrome: a critical reappraisal. J Cutan Pathol 1997; 24: 292.
3. Trotter MJ, Whittaker SJ, Orchard GE, et al. Cutaneous histopathology of Sezary syndrome: a study of 41 cases with a proven circulating T-cell clone. J Cutan Pathol 1997; 24: 286.
4. Glusac EJ, Shapiro PE, McNiff JM. Cutaneous T-cell lymphoma: refinement in the application of Controversial Histologic Criteria. Clin Dermatol 1999; 17: 601.
5. Odom RB, James WD, Berger TG. Andrews' diseases of the skin: clinical dermatology, Vol. 2. Philadelphia: Saunders, 2000; 252.
6. Walsh NMG, Prokopetz R, Tron VA, et al. Histopathology in erythroderma: review of a series of cases by multiple observers. J Cutan Pathol 1994; 21: 419.
7. Kamarashev J, Burg G, Kempf W, Hess Schmid M, Dummer R. Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome. J Cutan Pathol 1998; 25: 407.
8. Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma: a review of 222 biopsies, including newly described patterns and the earliest pathologic changes). Am J Surg Pathol 1994; 18: 645.
9. Lever WF, Schaumberg-Lever G. Histopathology of the skin, 7th ed. Philadelphia: Lippincott, 1990; 822.
10. Imai S, Burg G, Braun-Falco O. Mycosis fungoides and Sezary's syndrome show distinct histomorphological features. Dermatologica 1986; 173: 131.
11. Flaxman BA, Zelazny G, Van SE. Nonspecificity of characteristic cells in mycosis fungoides. Arch Dermatol 1971; 104: 141.
12. Yeh YA, Hudson AR, Prieto VG, Shea CR, Smoller BR. Reassessment of lymphocytic atypia in the diagnosis of mycosis fungoides. Mod Pathol 2001; 14: 285.
13. Vonderheid EC, Bernengo MG, Burg G, et al. Erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002; 46: 95.